Upstate Active Clinical Trials
Study Title:PERL Preventing Early Renal Loss in Diabetes: A multicenter clinical trial of allopurinol to prevent GFR loss in type 1 diabetes
What is the purpose of the study?The purpose of this study is to find out whether a medication called allopurinol can prevent kidney problems, in particular the loss of kidney function, in people with type 1 diabetes.
Upstate Institutional Review Board (IRB) Number:499866
Patient Age Group:Adults
Principal Investigator:Ruth S Weinstock, MD, PhD
What is involved if I participate?
- How long is the study?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Procedures during study visits include: physical exams, vital signs, blood collection, urinalysis, ECG, questionnaire completion.
Where will the study take place?Clinical Research Unit at IHP (505 Irving Ave.)
Who can I contact for more information?
Name: Suzan M Bzdick, RN